Abstract
The transient receptor potential vanilloid type-2 (TRPV2), belonging to the transient receptor potential channel family, is a specialized ion channel expressed in human and other mammalian immune cells. This channel has been found to be expressed in CD34+ hematopoietic stem cells, where its cytosolic Ca2+ activity is crucial for stem/progenitor cell cycle progression, growth, and differentiation. In innate immune cells, TRPV2 is expressed in granulocytes, macrophages, and monocytes where it stimulates fMet-Leu-Phe migration, zymosan-, immunoglobulin G-, and complement-mediated phagocytosis, and lipopolysaccharide-induced tumor necrosis factor-alpha and interleukin-6 production. In mast cells, activation of TRPV2 allows intracellular Ca2+ ions flux, thus stimulating protein kinase A-dependent degranulation. In addition, TRPV2 is highly expressed in CD56+ natural killer cells. TRPV2 orchestrates Ca2+ signal in T cell activation, proliferation, and effector functions. Moreover, messenger RNA for TRPV2 are expressed in CD4+ and CD8+ T lymphocytes. Finally, TRPV2 is expressed in CD19+ B lymphocytes where it regulates Ca2+ release during B cell development and activation. Overall, the specific expression of TRPV2 in immune cells suggests a role in immune-mediated diseases and offers new potential targets for immunomodulation.
TRPV2: A MEMBER OF THE TRP CHANNEL FAMILY
The 30 mammalian transient receptor potential (TRP) cation channels identified so far can be sorted into seven subfamilies: TRPC (canonical), TRPM (melastatin), TRPV (vanilloid), TRPA (ankyrin transmembrane protein), TRPP (polycystin), TRPML (mucolipin), and TRPN (NomPC-like). TRPs are essentially classified according to their primary amino acid sequence rather than selectivity or ligand affinity. From a structural standpoint, TRP channels are membrane proteins with six putative transmembrane spans (TMs) and a cation-permeable pore region formed by a short hydrophobic stretch between TM5 and TM6 (; Figure 1). TRP proteins are essentially cation-permeable ion channels sensitive to a remarkable range of stimuli. Genetic approaches in worms, flies, and mice have demonstrated the involvement of TRPs in a variety of sensory processes that include thermosensation, osmosensation, olfaction, taste, mechanosensation, vision, and pain perception. Remarkably, mutations in different TRPs have also been linked to human diseases ().
FIGURE 1
Among TRPV channels, TRPV2 is a non-selective cation channel showing Ca2+ permeability (). Its activation triggers an inward cation current (mainly Ca2+) that mediates a relatively broad repertoire of physiological functions in response to noxious heat, with an activation threshold of >52°C, as well as to changes in osmolarity and membrane stretch. Human TRPV2 (hTRPV2) channel is triggered by agonists such as ∆9-tetrahydrocannabinol (∆9-THC) and cannabidiol (CBD; ; ; ). It was found to be expressed both in the plasma membrane and early endosome. Activation of TRPV2 by growth factors causes PI-3K-dependent and independent translocation in the plasma membrane (; ). In addition, TRPV2 may serve as an endosomal calcium release channel that controls endosome fusion and/or exocytosis (; ). It has been demonstrated that TRPV2 expression and activity are increased following inflammation, by the action of growth factors such as insulin-like growth factor I (IGF-I; ). However, the contribute of TRPV2 to inflammation requires further investigations.
This work summarizes data reported in the literature on the expression and function of TRPV2 in hematopoietic stem cells (HSCs) and in natural and adaptive immune cells (Table 1).
Table 1
| Cell type | Species | TRPV2-mediated effect | Reference |
|---|---|---|---|
| Neutrophils | Human | Migration | |
| Monocytes/ macrophages | Mouse | Migration | |
| Mouse | Phagocytosis | ||
| Mouse | Cytokine production? | ||
| Mouse | Differentiation | ||
| Mast cells | Human | Degranulation | Zhang et al. (2012) |
| T cells | Human | T cell receptor and Ca2+ signaling |
Role of TRPV2 in immune cells.
EXPRESSION OF TRPV2 IN HSCs
Stem cells are found in all multi-cellular organisms and are characterized by the ability to self-renew through mitotic cell division and differentiate into a range of specialized cell types. Multiple functional ion channel currents have been reported to be heterogeneously present in different types of stem cells. They include the voltage-gated delayed rectifier K+ current (IKDR), the Ca2+-activated K+ current (KCa), inward rectifier K+ current, hyperpolarization-activated cyclic nucleotide regulated cation current, chloride current, voltage-gated Na+ current, L-type calcium current, and TRP non-selective cation currents ().
While these channels are key players in the pathophysiology of excitable cells, a wide variety of ion channels are also expressed by non-excitable cells, such as cells of the immune system, where they function in signaling pathways regulating electrolyte transport, cell volume, proliferation, differentiation, and apoptosis.
CD34+ HSCs give rise to all types of blood cells from the myeloid (monocytes, neutrophils, erythrocytes, dendritic cells, etc.) and lymphoid lineages [T cells, B cells, and natural killer (NK) cells].
Cytosolic Ca2+ activity is crucial for stem/progenitor cell cycle progression and growth (; ). Primary human CD34+ HSCs express voltage-gated K+ channels, two-pore domain background K+ channels, and TRP non-selective cation channel family. By using fluorescent-activated cell sorting (FACS) and reverse transcriptase-polymerase chain reaction (RT-PCR), it has been found that human CD34+/CD45+/CD133+CD73- HSCs express TRPV2 channels (). Despite the limitation in applying higher temperature conditions, a 42°C TRPV2-like current was consistently observed in CD34+ HSCs. These data are in accordance with the previously reported transcriptoma analysis evaluated by GNF gene expression () suggesting a peculiar expression of TRPV2 mRNA in CD34+ HSCs (Figure 2). Recently, we have demonstrated, both at mRNA and protein levels, that human neural stem cells (NSCs) and glioblastoma stem-like cells (GSCs) express TRPV2 (), as reminiscence of the primitive myeloid progenitors ().
FIGURE 2
TRPV2 CHANNELS IN CELLS OF NATURAL IMMUNITY
Innate immunity, also called natural or native immunity, consists of cellular and biochemical defense mechanisms in place before infection and poised to respond rapidly to infections. The natural immune system includes cells of both myeloid and lymphoid origin, monocytes, macrophages, granulocytes, dendritic cells, and mastocytes as well as NK cells. These cells express many channels belonging to the TRP channel family. Among these, we focused our attention on the expression and function of TRPV2.
GRANULOCYTES
Immune cells kill microbes by engulfing them in a membrane-enclosed compartment, the phagosome. Phagocytosis is initiated when foreign particles bind to receptors on the membrane of phagocytes. The best-studied phagocytic receptors, those for immunoglobulins (FcγR) and for complement proteins (CR), activate phospholipase C (PLC) and D (PLD), resulting in the intracellular production of Ca2+. The molecules that mediate Ca2+ ion flux across the phagosomal membrane are still unknown but likely include the ubiquitous store-operated Ca2+ entry (SOCE) channels, ligand-gated chloride channel (LGCC), voltage-gated Ca2+ channel (VGCC), and TRP channels.
TRPV2 mRNA has been demonstrated in human neutrophil granulocytes by RT-PCR (
MONOCYTES AND MACROPHAGES
TRPV2 gene expression data identify mRNA expression in human CD33+ myeloid cells and CD14+ monocytes. RT-PCR and immunoblot analyses have shown that TRPV2 is the sole member of the TRPV family expressed in mouse macrophages (
It has been recently demonstrated (
A role of TRPV2 in early phagocytosis and its fundamental importance in innate immunity was demonstrated in mice by
FIGURE 3

A model for the involvement of TRPV2 in phagocytosis. (A) Engagement of oligomeric ligands with receptors in the absence of obvious receptor clustering leads to activation of TRPV2 in a PI(3)K-dependent manner, which results in membrane depolarization. How signals downstream of PI(3)K activate TRPV2 remains unclear. Phosphorylation of TRPV2, oligomerization of TRPV2, or recruitment of TRPV2 from intracellular compartment may trigger TRPV2 activation. (B) PtdIns(4,5)P2 (PI(4,5)P2) is synthesized by a combination of type II PI(4)K activated by membrane polarization and PIP(5)Kγ activated by Syk. PtdIns(4,5)P2 recruits actin-binding proteins for local actin depolymerization to change local plasma membrane fluidity, thus allowing FcγRs to move. (C) Higher order FcγR clustering strengthens the FcγR-mediated signaling, resulting in the activation of PIP(5)Kα and the generation of more PtdIns(4,5)P2, which is sufficient for actin polymerization with the aid of Wiskott–Aldrich syndrome protein (WASp) and Arp2/3. Actin polymerization induces pseudopodia and phagosomal cup formation. PtdIns(4,5)P2, FcγR, and TRPV2 are concentrated in the phagosomal cup. PI, phosphoinositide; PI(4)P, phosphatidylinositol-4-phosphate; PI(3,4,5)P3, phosphatidylinositol-3,4,5-trisphosphate; PKC, protein kinase C; ER, endoplasmic reticulum. From
Several studies have indicated that intracellular Ca2+ is a second messenger in Toll-like receptor 4 (TLR4)-dependent signaling. Recently, a role of TRPV2 in lipopolysaccharide (LPS)-induced cytokine mRNA production in mouse macrophages has been demonstrated (
Recently, it has been demonstrated that the receptor activator of NF-κB ligand (RANKL) induces TRPV2 expression and regulates mouse osteoclast differentiation (osteoclastogenesis) via calcium oscillations and activation of the nuclear factor of activated T cells 1 (NFATc1;
DENDRITIC CELLS
At present very few data have been provided on the expression of TRPV2 in dendritic cells in human. TRPV2 gene expression was identified in human dendritic cells, but no functional data have been provided so far (
NK CELLS
TRPV2 gene is 10- to 30-fold more expressed in human CD56+ NK cells compared to all the other cells of both innate and adaptive systems (
MAST CELLS
Mast cells are tissue-resident immune effector cells. They respond to diverse stimuli by releasing potent biological mediators into the surrounding tissue, and initiating inflammatory responses that promote wound healing and infection clearance. In addition to stimulation via immunological routes, mast cells also respond to polybasic secretagogues and physical stimuli. Each mechanism for mast cell activation relies on the influx of calcium through specific ion channels in the plasma membrane (
The expression, surface localization, and oligomerization of TRPV2 protein subunits together with functional coupling of TRPV2 protein to calcium fluxes and proinflammatory degranulation events have been reported in mast cells (
A characteristic of TRPV2 is its activation by high noxious temperature; temperatures exceeding 50°C induced a ruthenium red-sensitive current. In addition, laser light of 640 nm or light at 48 mW for 20 min induced current sensitive to SKF96365, a selective inhibitor of receptor-mediated Ca2+ entry and voltage-gated Ca2+ entry. Thus, all the three physical stimuli able to activate the TRPV2 channel-induced pronounced degranulation in human mast cells, which could be blocked by ruthenium red or SKF96365. Activation of TRPV2 allows Ca2+ ions to enter the cell, which in turn induce degranulation, suggesting that TRPV2 plays a key role in mast cell degranulation in response to mechanical, heat, and red laser light stimulation (Zhang et al., 2012).
TRPV2 CHANNELS IN ADAPTIVE IMMUNITY
T LYMPHOCYTES
Calcium acts as a second messenger in many cell types, including lymphocytes. Resting lymphocytes maintain a low concentration of Ca2+ (
By quantitative RT-PCR (qRT-PCR), TRPV2 mRNA was detected in whole peripheral blood, primary human T cells (
B LYMPHOCYTES
At present, the literature offers very little information on the expression of TRPV2 mRNA and protein in human. Using GNF gene analysis, the expression of TRPV2 mRNA was found in whole blood, lymph nodes and tonsils, and human CD19+ B lymphocytes (
Information about the expression and function of TRPV2 in B lymphocytes was provided by
Overall, it is conceivable that TRPV2 acts as a transmembrane protein expressed on the surface of B cells, and that it negatively controls Ca2+ flux-activated proliferative signal transduction pathways and B cell activation at immunological synaptic level. Thus, the inhibitory role showed by TRPV2 in in vivo B cell number, could be the result of CBD-induced translocation of TRPV2 from the cytosol to the plasma membrane (
FIGURE 4

A model for the involvement of TRPV2 B cell activity regulation. (A) In normal conditions, B cell receptor (BCR) activation induces calcium channels translocation and activation, resulting result in B cell activation and proliferation. (B) Growth factors or cytokines, by inducing PI(3)K-dependent or independent pathways, may induce TRPV2 translocation and activation, resulting in calcium overload, B cell activation shut-down and induction of pro-apoptotic cell death pathways, in a similar way to CD20.
It has also been suggested that TRPV2 plays an important role in regulating Ca2+ release during B cell development. Thus, the promoter of TRPV2 shows binding sites for regulatory transcription factors such as AP2rep, NF-AT1, NF-AT2, and NF-AT3 as well as for Bach-2 (
TRPV2 channel has been found to be associated with the recombinase gene activator protein during biosynthesis and early trafficking; it has been observed that over-expression of RGA protein potentiates basal surface localization of TRPV2 and cyclic adenosine monophosphate (cAMP) signal in human non-sensory cells (
CONCLUSION
The TRPV2 is a specialized ion channel expressed in mammalian innate and adaptive immune system. Recent findings on the TRPV2-mediated migration and phagocytosis of granulocytes and macrophages, PKA-dependent mast cell degranulation and its hypothesized role in NK cell cytotoxicity, strongly suggest a major role played by TRPV2 in the control of innate immune responses. Moreover, research on the involvement of TRPV2 as negative transductor in T and B cell activation is still at the beginning. One recent finding is the expression of TRPV2 in a chronic inflammatory skin diseases of unknown etiology called erythematotelangiectatic and papulopustular rosacea (
Genetic approaches are required to advance a causal understanding on the role of TRPV2 in inflammatory immune-mediated diseases and cancer. These approaches include over-expression of dominant negative variants, antisense oligonucleotides, and siRNA.
Moreover, although the search for natural TRPV2 ligands and chemical modulators as therapeutic agents has been intensified in the last years (e.g., synthetic and endogenous cannabinoids), specific agonists or blockers and a specific monoclonal anti-hTRPV2 antibody are still lacking.
Further study should be performed to completely address the role of TRPV2 in the pathophysiology of the immune system.
Statements
Acknowledgments
This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) National Grant 2011–2013 (Number 11095).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
REFERENCES
1
AbeK.PuertollanoR. (2011). Role of TRP channels in the regulation of the endosomal pathway.Physiology2614–22.
2
AgudeloM.NewtonC.WidenR.SherwoodT.NongL.FriedmanH.et al (2008). Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in culture of murine-purified B lymphocytes.J. Neuroimmune Pharmacol.335–42.
3
BarnhillJ. C.StokesA. J.Koblan-HubersonM.ShimodaL. M.MuraguchiA.AdraC. N.et al (2004). RGA protein associates with a TRPV ion channel during biosynthesis and trafficking.J. Cell. Biochem.91808–820.
4
BoydR. S.Jukes-JonesR.WalewskaR.BrownD.DyerM. J.CainK. (2009). Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma.Mol. Cell. Proteomics81501–1515.
5
BubienJ. K.ZhouL. J.BellP. D.FrizzellR. A.TedderT. F. (1993). Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes.J. Cell Biol.1211121–1132.
6
CahalanM. D.ChandyK. G. (2009). The functional network of ion channels in T lymphocytes.Immunol. Rev.23159–87.
7
CaterinaM. J.RosenT. A.TominagaM.BrakeA. J.JuliusD. (1999). A capsaicin-receptor homologue with a high threshold for noxious heat.Nature398436–441.
8
CuiJ.BianJ. S.KaganA.McDonaldT. V. (2002). CaT1 contributes to the stores-operated calcium current in Jurkat T-lymphocytes.J. Biol. Chem.27747175–47183.
9
Ferreira-MartinsJ.Rondon-ClavoC.TugalD.KornJ. A.RizziR.Padin-IruegasM. E.et al (2009). Spontaneous calcium oscillations regulate human cardiac progenitor cell growth.Circ. Res.105764–774.
10
FreichelM.AlmeringJ.TsvilovskyyV. (2012). The role of TRP proteins in Mast cells.Front. Immunol. 3:150. 10.3389/fimmu.2012.00150
11
GinhouxF.GreterM.LeboeufM.NandiS.SeeP.GokhanS.et al (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages.Science330841–845.
12
HeinerI.EisfeldJLückhoffA. (2003). Role and regulation of TRP channels in neutrophil granulocytes.Cell Calcium33533–540.
13
Ignatowska-JankowskaB.JankowskiM.GlacW.SwiergelA. H. (2009). Cannabidiol-induced lymphopenia does not involve NKT and NK cells.J. Physiol. Pharmacol.6099–103.
14
KajiyaH.OkamotoF.NemotoT.KimachiK.Toh-GotoK.NakayanaS.et al (2010). RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations.Cell Calcium48260–269.
15
KanzakiM.ZhangY. Q.MashimaH.LiL.ShibataH.KojimaI. (1999). Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I.Nat. Cell Biol.1165–170.
16
KimC. S.KawadaT.KimB. S.HanI. S.ChoeS. Y.KurataT.et al (2003). Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages.Cell. Signal.15299–306.
17
KowaseT.NakazatoY.Yoko-OH.MorikawaA.KojimaI. (2002). Immunohistochemical localization of growth factor-regulated channel (GRC) in human tissues.Endocr. J.49349–355.
18
KoyasuS. (2010). Vanilloid flavor for a good appetite? Nat. Immunol.11187–189.
19
LiG. R.DengX. L. (2011). Functional ion channels in stem cells.World J. Stem Cells319–24.
20
LinkT. M.ParkU.VonakisB. M.RabenD. M.SoloskiM. J.CaterinaM. J. (2010). TRPV2 has a pivotal role in macrophage particle binding and phagocytosis.Nat. Immunol.11232–239.
21
LioudynoM. I.KozakJ. A.PennaA.SafrinaO.ZhangS. L.SenD.et al (2008). Orai and STIM1 move to the immunological synapse and are up-regulated during T cell activation.Proc. Natl. Acad. Sci. U.S.A.1052011–2016.
22
MorelliM. B.NabissiM.AmantiniC.FarfarielloV.Ricci-VitianiL.di MartinoS.et al (2012). The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.Int. J. Cancer131E1067–E1077.
23
MutoA.TashiroS.NakajimaO.HoshinoH.TakahashiS.SakodaE.et al (2004). The transcriptional programme of antibody class switching involves the repressor Bach2.Nature429566–571.
24
NabissiM.MorelliM. B.AmantiniC.FarfarielloV.Ricci-VitianiL.CaprodossiS.et al (2010). TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner.Carcinogenesis31794–803.
25
NabissiM.MorelliM. B.SantoniM.SantoniG. (2013). Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.Carcinogenesis3448–57.
26
NagasawaM.NakagawaY.TanakaS.KojimaI. (2007). Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages.J. Cell. Physiol.210692–702.
27
NeeperM. P.LiuY.HutchinsonT. L.WangY.FloresC. M.QinN. (2007). Activation properties of heterologously expressed mammalian TRPV2: evidence for species dependence.J. Biol. Chem.28215894–15902.
28
NiliusB.OwsianikG.VoetsT.PetersJ. A. (2007). Transient receptor potential cation channels in disease.Physiol. Rev.87165–217.
29
OwsianikG.D’HoedtD.VoetsT.NiliusB. (2006). Structure–function relationship of the TRP channel superfamily.Rev. Physiol. Biochem. Pharmacol.15661–90.
30
ParkK. S.PangB.ParkS. J.LeeY. G.BaeJ. Y.ParkS.et al (2011). Identification and functional characterization of ion channels in CD34(+) hematopoietic stem cells from human peripheral blood.Mol. Cells32181–188.
31
PennaA.JuvinV.CheminJ.CompanV.MonetM.RassendrenF. A. (2006). Pl3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane.Cell Calcium39495–507.
32
QinN.NeeperM. P.LiuY.HutchinsonT. L.LubinM. L.FloresC. M. (2008). TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons.J. Neurosci.286231–6238.
33
ResendeR. R.AdhikariA.da CostaJ. L.LorençconE.LadeiraM. S.GuatimosimS.et al (2010). Influence of spontaneous calcium events on cell-cycle progression in embryonal carcinoma and adult stem cells.Biochim. Biophys. Acta1803246–260.
34
SaitoM.HansonP. I.SchlesingerP. (2007). Luminal chloride-dependent activation of endosome calcium channels. Patch clamp study of enlarged endosomes.J. Biol. Chem.28227327–27333.
35
SauerK. JeglaT. J. (2006). Methods for Identifying T Cell Activation Modulating Compounds.Patent Application WO/2006/065613.
36
SaundersC. I.KundeD. A.CrawfordA.GeraghtyD. P. (2007). Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood.Mol. Immunol.441429–1435.
37
SchwarzE. C.WolfsM. J.TonnerS.WenningA. S.QuintanaA.GriesemerD.et al (2007). TRP channels in lymphocytes.Handb. Exp. Pharmacol.179445–456.
38
ShimosatoG.AmayaF.UedaM.TanakaY.DecosterdI.TanakaM. (2005). Peripheral inflammation induces up-regulation of TRPV2 expression in rat DRG.Pain119225–232.
39
SpinsantiG.ZannolliR.PantiC.CeccarelliI.MarsiliL.BachioccoV.et al (2008). Quantitative real-time PCR detection of TRPV1-4 gene expression in human leukocytes from healthy and hyposensitive subjects.Mol. Pain451.
40
SrivastavaM. D.SrivastavaB. I.BrouhardB. (1998). Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.Immunopharmacology40179–185.
41
StokesA. J.ShimodaL. M.Koblan-HubersonM.AdraC. N.TurnerH. (2004). TRPV2-PKA signaling module for transduction of physical stimuli in mast cells.J. Exp. Med.200137–147.
42
StokesA. J.WakanoC.Del CarmenK. A.Koblan-HubersonM.TurnerH. (2005). Formation of a physiological complex between TRPV2 and RGA protein promotes cell surface expression of TRPV2.J. Cell. Biochem.94669–683.
43
SuA. I.WiltshireT.BatalovS.LappH.ChingK. A.BlockD.et al (2004). A gene atlas of the mouse and human protein-encoding transcriptomes.Proc. Natl. Acad. Sci. U.S.A.1016062–6067.
44
SulkM.SeeligerS.AubertJ.SchwabV. D.CevikbasF.RivierM.et al (2012). . Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea.J. Invest. Dermatol.1321253–1262.
45
TedderT. F.EngelP. (1994). CD20: a regulator of cell-cycle progression of B lymphocytes.Immunol. Today15450–454.
46
TurnerH.del CarmenK. A.StokesA. (2007). Link between TRPV channels and mast cell function.Handb. Exp. Pharmacol.179457–471.
47
VigM.KinetJ. P. (2009). Calcium signaling in immune cells.Nat. Immunol.1021–27.
48
YamashiroK.SasanoT.TojoK.NamekataI.KurokawaJ.SawadaN.et al (2010). Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages.Biochem. Biophys. Res. Commun.398284–289.
49
YuanM.KiertscherS. M.ChengQ.ZoumalanR.TashkinD. P.RothM. D. (2002). Delta 9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells.J. Neuroimmunol.133124–131.
50
ZhangD.SpielmannA.WangL.DingG.HuangF.GuQ.et al (2012). Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2.Physiol. Res.61113–124.
Summary
Keywords
transient receptor potential, transient receptor potential vanilloid type-2, macrophages, mastocytes, T cell activation, B cell activation, immuno-mediated-diseases, immunomodulation
Citation
Santoni G, Farfariello V, Liberati S, Morelli MB, Nabissi M, Santoni M and Amantini C (2013) The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses. Front. Immun. 4:34. doi: 10.3389/fimmu.2013.00034
Received
13 December 2012
Accepted
30 January 2013
Published
14 February 2013
Volume
4 - 2013
Edited by
Masaaki Murakami, Osaka University, Japan
Reviewed by
Daisuke Kamimura, Osaka University, Japan; Hideki Ogura, Osaka University, Japan
Copyright
© Santoni, Farfariello, Liberati, Morelli, Nabissi, Santoni and Amantini.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
*Correspondence: Giorgio Santoni, Section of Experimental Medicine, School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, Italy. e-mail: giorgio.santoni@unicam.it
This article was submitted to Frontiers in Inflammation, a specialty of Frontiers in Immunology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.